Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 26,784 | 24,524 | 20,034 | 18,927 | 16,323 |
| Operating Income | -26,784 | -24,524 | -20,034 | -18,927 | -16,323 |
| Interest Expense | 385 | 370 | 349 | 310 | 272 |
| Other Income | 2,861 | 2,695 | 2,202 | 1,390 | 408 |
| Pre-tax Income | -24,308 | -22,199 | -18,181 | -17,847 | -16,187 |
| Net Income Continuous | -24,308 | -22,199 | -18,181 | -17,847 | -16,187 |
| Net Income | $-24,308 | $-22,199 | $-18,181 | $-17,847 | $-16,187 |
| EPS Basic Total Ops | -3.40 | -3.10 | -2.53 | -2.50 | -2.50 |
| EPS Basic Continuous Ops | -3.35 | -3.07 | -2.49 | -2.47 | -2.52 |
| EPS Diluted Total Ops | -3.40 | -3.10 | -2.53 | -2.50 | -2.50 |
| EPS Diluted Continuous Ops | -3.35 | -3.07 | -2.49 | -2.47 | -2.52 |
| EBITDA(a) | $-28,295 | $-25,919 | $-21,619 | $-19,041 | $-15,599 |